New skin cream GZ21T passes first safety check in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested a new cream called GZ21T in 41 healthy adults to see if it is safe and how the body absorbs it. The cream is being developed for actinic keratosis, a skin condition that can lead to cancer. No treatment was given; the goal was only to check for side …
Phase: PHASE1 • Sponsor: Genzada Pharmaceuticals USA, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC